0001567619-20-002243.txt : 20200205 0001567619-20-002243.hdr.sgml : 20200205 20200205165926 ACCESSION NUMBER: 0001567619-20-002243 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 EFFECTIVENESS DATE: 20200205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SEN-JAM PHARMACEUTICAL LLC CENTRAL INDEX KEY: 0001802249 IRS NUMBER: 822750291 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-359878 FILM NUMBER: 20579568 BUSINESS ADDRESS: STREET 1: 223 WALL STREET, #130 CITY: HUNTINGTON STATE: NY ZIP: 11743 BUSINESS PHONE: 201-400-8083 MAIL ADDRESS: STREET 1: 223 WALL STREET, #130 CITY: HUNTINGTON STATE: NY ZIP: 11743 D 1 primary_doc.xml X0708 D LIVE 0001802249 SEN-JAM PHARMACEUTICAL LLC 223 WALL STREET, #130 HUNTINGTON NY NEW YORK 11743 201-400-8083 DELAWARE None None Limited Liability Company true 2017 James 223 Wall Street Iversen #130 Huntington NY NEW YORK 11743 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-01-28 false true false 0 3000000 0 3000000 false 2 0 0 0 false SEN-JAM PHARMACEUTICAL LLC /s/ James Iversen James Iversen CEO 2020-02-05